Insulin aspart protamine and insulin aspart Subcutaneous and Oritavancin Diphosphate
Determining the interaction of Insulin aspart protamine and insulin aspart Subcutaneous and Oritavancin Diphosphate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
Generic Name: oritavancin
Brand name: Orbactiv
Synonyms: Oritavancin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart protamine and insulin aspart Subcutaneous-Oritavancin Intravenous
- Insulin aspart protamine and insulin aspart Subcutaneous-Orkambi
- Insulin aspart protamine and insulin aspart Subcutaneous-Orkambi (Lumacaftor and Ivacaftor Granules)
- Insulin aspart protamine and insulin aspart Subcutaneous-Orkambi (Lumacaftor and Ivacaftor Tablets)
- Insulin aspart protamine and insulin aspart Subcutaneous-Orlistat
- Insulin aspart protamine and insulin aspart Subcutaneous-Ornex
- Oritavancin Diphosphate-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Oritavancin Diphosphate-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Oritavancin Diphosphate-Insulin Aspart Protamine Injection
- Oritavancin Diphosphate-Insulin aspart, recombinant Subcutaneous
- Oritavancin Diphosphate-Insulin degludec
- Oritavancin Diphosphate-Insulin Degludec (U-100) Prefilled Pens